ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 234,35
0,57%
Dow Jones
39 387,76
0,85%
DAX
18 805,29
0,67%
Brent Oil
83,855
-0,11%
Bitcoin
63 006,50
-0,07%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Eledon Pharmaceuticals Inc (ELDN)

  7. Eledon Pharmaceuticals Inc (ELDN) Actualités

ELDN Eledon Pharmaceuticals Inc

2,40
0,00 (0,00%)
Avant marché
Dernière mise à jour : 10:16:21
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Eledon Pharmaceuticals Inc ELDN NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 2,40 10:16:21
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
2,40
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
09/5/202413:30GLOBEEledon Pharmaceuticals Reports First Quarter 2024 Operating..
09/5/202413:00GLOBEEledon Pharmaceuticals to Present Updated Data from Ongoing..
07/5/202413:15EDGAR2Form 8-K - Current report
07/5/202413:05GLOBEEledon Announces Clinical Progress with Tegoprubart in the..
07/5/202413:00GLOBEEledon Pharmaceuticals Announces Oversubscribed $50 Million..
28/3/202421:01GLOBEEledon Pharmaceuticals Reports Fourth Quarter and Full Year..
25/3/202421:56GLOBEEledon Pharmaceuticals Announces 12th Participant Enrolled..
21/3/202415:31GLOBEEledon Pharmaceuticals Announces Use of Tegoprubart in..
14/2/202421:35EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/2/202421:01EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202401:01GLOBEEledon Reports Inducement Grants Under Nasdaq Listing Rule..
04/1/202422:40GLOBEEledon Pharmaceuticals Highlights Recent Business Milestones..
05/12/202300:00GLOBEEledon Reports Inducement Grants Under Nasdaq Listing Rule..
29/11/202322:05GLOBEEledon Pharmaceuticals to Present at Noble Capital Markets'..
09/11/202323:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202322:01GLOBEEledon Pharmaceuticals Reports Third Quarter 2023 Operating..
08/11/202322:05GLOBEEledon Pharmaceuticals to Present at Jefferies London..
02/11/202321:30EDGAR2Form 8-K - Current report
02/11/202314:05GLOBEEledon Reports Updated Data from Ongoing Phase 1b Trial..
23/10/202313:00GLOBEEledon Pharmaceuticals Strengthens Leadership Team with..
13/10/202313:00GLOBEEledon Pharmaceuticals to Present Data from Ongoing Phase 1b..
03/10/202322:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202322:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202323:51EDGAR2Form 3 - Initial statement of beneficial ownership of..
02/10/202323:08EDGAR2Form 3 - Initial statement of beneficial ownership of..
02/10/202313:30EDGAR2Form 8-K - Current report
02/10/202313:00GLOBEEledon Pharmaceuticals Appoints Kidney Transplant Specialist..
25/9/202313:00GLOBEEledon Pharmaceuticals Announces Use of Tegoprubart..
20/9/202322:05GLOBEEledon Pharmaceuticals to Participate at the 2023 Cantor..
13/9/202322:42EDGAR2Form 8-K - Current report
11/9/202313:00GLOBEEledon Pharmaceuticals Appoints Industry Veteran James..
06/9/202313:00GLOBEEledon Pharmaceuticals Announces Publication of Data Showing..
05/9/202313:00GLOBEEledon Pharmaceuticals Announces First Participant Dosed in..
16/8/202313:00GLOBEEledon Pharmaceuticals Announces Dosing of 10th Patient in..
10/8/202323:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202313:05EDGAR2Form 8-K - Current report
10/8/202313:00GLOBEEledon Pharmaceuticals Reports Second Quarter 2023 Operating..
02/6/202314:00GLOBEEledon Pharmaceuticals to Present at Jefferies Healthcare..
11/5/202322:01GLOBEEledon Pharmaceuticals Reports First Quarter 2023 Operating..

Dernières Valeurs Consultées

NASDAQ
ELDN
Eledon Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés